Thrombocytopenia in a patient with rheumatoid arthritis during sulphasalazine therapy
Keso, L.; Kaarela, K.; Oksanen, K.; Ahonen, M.
Duodecim; Laaketieteellinen Aikakauskirja 114(17): 1731-1733
1998
ISSN/ISBN: 0012-7183 PMID: 11717780 Document Number: 484804
Document emailed within 1 workday
Related Documents
Georgescu, C. 1992: Sulphasalazine therapy in rheumatoid arthritis. a two-year study and follow-up of clinical results Romanian Journal of Internal Medicine 30(2): 127-132Rachwał-Siek, K.; Ponikowska, M.; Wiland, P. 2011: Toxic epidermal necrolysis during therapy with sulphasalazine in a patient with arthritis. Case report Wiadomosci Lekarskie 64(4): 283-287
Bax, D.E.; Greaves, M.S.; Amos, R.S. 1986: Sulphasalazine treatment in rheumatoid arthritis Journal of Rheumatology 13(2): 463-464
Islam, M.N.; Alam, M.N.; Haq, S.A.; Moyenuzzaman, M.; Patwary, M.I.; Rahman, M.H. 2000: Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis Bangladesh Medical Research Council Bulletin 26(1): 1-7
Shenoy, P.; Misra, R.; Jain, M.; Agarwal, V. 2008: Lymphoma-like presentation in suspected rheumatoid arthritis due to sulphasalazine hypersensitivity syndrome New Zealand Medical Journal 121(1276): 102-105
Pullar, T.; Hunter, J.A.; Capell, H.A. 1985: Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy British Journal of Rheumatology 24(3): 269-276
Dawes, P.T.; Sheeran, T.P.; Fowler, P.D.; Shadforth, M.F. 1987: Improving the response to gold or D-penicillamine by addition of sulphasalazine. a pilot study in 25 patients with rheumatoid arthritis Clinical and Experimental Rheumatology 5(2): 151-153
Itoh, K. 1992: Intra-articular injection therapy in patient with rheumatoid arthritis Nihon Rinsho. Japanese Journal of Clinical Medicine 50(3): 531-535
Olson, J.C.; Lovell, D.J.; Levinson, J.E. 1986: Hypogammaglobulinemia associated with gold therapy in a patient with juvenile rheumatoid arthritis Journal of Rheumatology 13(1): 224-225
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Krause, D.; Gabriel, B.; Herborn, G.; Braun, J.; Rau, R. 2015: Radiologic damage at baseline predicts patient-related outcomes 18 years after the initiation of methotrexate therapy in patients with severe rheumatoid arthritis Clinical and Experimental Rheumatology 33(5): 611-616
Yoshinoya, S.; Hashimoto, A.; Murata, K.; Miyamoto, T.; Kikuchi, F.; Nagashima, K. 1985: Rheumatoid valvular lesions of the aortic valve in a patient with a malignant course of rheumatoid arthritis Ryumachi 25(1): 20-29
Moore, F.L.; Osborn, T.G. 1986: 19S IgM rheumatoid factor plaque forming cells in a five-year-old patient with juvenile rheumatoid arthritis Journal of Rheumatology 13(4): 829-830
Dorwart, B.B.; Abrutyn, E.; Schumacher, H.R. 1973: Serratia arthritis. Medical eradication of infection in a patient with rheumatoid arthritis JAMA 225(13): 1642-1643
Tomiyama, H.; Takara, I.; Tokumine, J.; Sugahara, K. 2004: Sivelestat sodium hydrate was effective for ARDS in a patient suffering from chronic rheumatoid arthritis with acute exacerbation after failing to respond to high dose steroid pulse therapy Masui. Japanese Journal of Anesthesiology 53(9): 1042-1046
Salaffi, F.; Migliore, A.; Scarpellini, M.; Corsaro, S.M.; Laganà, B.; Mozzani, F.; Varcasia, G.; Pusceddu, M.; Pomponio, G.; Romeo, N.; Maier, A.; Foti, R.; Scarpa, R.; Gasparini, S.; Bombardieri, S. 2010: Psychometric properties of an index of three patient reported outcome (PRO) measures, termed the CLinical ARthritis Activity (PRO-CLARA) in patients with rheumatoid arthritis. The NEW INDICES study Clinical and experimental rheumatology 28(2): 186-200
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162
Henrard, J.C.; Bennett, P.H.; Burch, T.A. 1974: Epidemiology of rheumatoid arthritis. Evaluation of the so-called Rome and new York criteria for the diagnosis of rheumatoid arthritis in a population study Revue du Rhumatisme et des Maladies Osteo-Articulaires 41(11): 675-683
Barrera, P.; Balsa, A.; Alves, H.; Westhovens, R.; Maenaut, K.; Cornélis, F.; Fritz, P.; Bardin, T.; Ceu Maia, M.; Lopes-Vaz, A.; Pascual Salcedo, D.; de la Concha, E.; Radstake, T.; van de Putte, L.B.; Migliorini, P.; Prudhomme, J.F.; Charron, D.; Spyropoulou, M.; Mendes, A.; Spaepen, M.; Martinez, M.; Stavropoulos, C. 2001: Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF) Journal of Rheumatology 28(5): 968-974
Chen, J.R.; Takahashi, M.; Suzuki, M.; Kushida, K.; Miyamoto, S.; Inoue, T. 1998: Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis Journal of Rheumatology 25(12): 2440-2444